Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
NCT05957198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114921
Last updated 2024-11-21
Summary
The purpose of this study is to describe initiation and use of oxygen therapy among patients with fibrotic Interstitial Lung Disease (ILD) and to assess the impact of oxygen therapy on clinical outcomes among patients with fibrotic ILD.
Conditions
- Lung Diseases, Interstitial
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-25
- Primary Completion
- 2023-09-26
- Completion
- 2023-09-26
Countries
- United States
Study Locations
More Related Trials
-
P4O2 ILD Extension
NCT06644144 ·Status: RECRUITING
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
NCT05492994 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis
NCT03744598 ·Status: TERMINATED
-
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
NCT01915511 ·Status: RECRUITING
-
Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)
NCT05998512 ·Status: RECRUITING
-
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
NCT03958071 ·Status: COMPLETED
-
Interstitial Lung Disease Exacerbations Study
NCT06685874 ·Status: ACTIVE_NOT_RECRUITING
-
Interstitial Lung Disease Questionnaire
NCT01711151 ·Status: UNKNOWN
-
Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease
NCT07141810 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Interstitial Lung Diseases in the Veterans Administration
NCT02479126 ·Status: UNKNOWN
-
ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care
NCT05662124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
NCT00631475 ·Status: COMPLETED ·Phase: PHASE3
-
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
NCT05310669 ·Status: RECRUITING
-
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
NCT03478826 ·Status: RECRUITING
-
Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life
NCT03420235 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
NCT01710449 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure
NCT06855004 ·Status: RECRUITING
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
NCT00005317 ·Status: COMPLETED
-
Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis
NCT02399241 ·Status: COMPLETED ·Phase: NA
-
Xenon MRI and Progressive ILD
NCT05241275 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
NCT05609201 ·Status: ENROLLING_BY_INVITATION
-
Functional Respiratory Imaging in Bronchiectasis
NCT03818646 ·Status: UNKNOWN
-
Dose Reduction and Discontinuation With Anti-Fibrotic Medications
NCT05779007 ·Status: COMPLETED